{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:48:15Z","timestamp":1788526095605,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.meegid.2017.05.022","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:02:48Z","timestamp":1495522968000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach"],"prefix":"10.1016","volume":"53","author":[{"given":"Manju","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2017.05.022_bb0005","series-title":"Control of Visceral Leishmaniasis by Immunotherapeutic and Prophylactic Strategies","first-page":"84","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I-and II-restricted epitopes of four known Leishmania infantum proteins","author":"Agallou","year":"2015"},{"key":"10.1016\/j.meegid.2017.05.022_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/09723757.2001.11885772","article-title":"Distribution of HLA class II antigens in three North Indian populations","volume":"1","author":"Agrawal","year":"2001","journal-title":"Int. J. Hum. Genet."},{"key":"10.1016\/j.meegid.2017.05.022_bb0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-0039.2008.01083.x","article-title":"Genetic affinities of north and northeastern populations of India: inference from HLA-based study","volume":"72","author":"Agrawal","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.meegid.2017.05.022_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2307\/3284319","article-title":"Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes","author":"Ali","year":"1997","journal-title":"J. Parasitol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00251-015-0873-y","article-title":"Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification","volume":"67","author":"Andreatta","year":"2015","journal-title":"Immunogenetics"},{"key":"10.1016\/j.meegid.2017.05.022_bb0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-6-296","article-title":"Oligomeric protein structure networks: insights into protein-protein interactions","volume":"6","author":"Brinda","year":"2005","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.meegid.2017.05.022_bb0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1440-1711.2002.01088.x","article-title":"Prediction of promiscuous peptides that bind HLA class I molecules","volume":"80","author":"Brusic","year":"2002","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0045","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+ MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.05.022_bb0050","first-page":"1","article-title":"Amino acid side-chain hydrophobicity","author":"Chan","year":"2002","journal-title":"eLS"},{"key":"10.1016\/j.meegid.2017.05.022_bb0055","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.meegid.2017.05.022_bb0060","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2017.05.022_bb0065","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1172\/JCI41281","article-title":"Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice","volume":"120","author":"Dalton","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2017.05.022_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.drudis.2007.03.010","article-title":"Harnessing bioinformatics to discover new vaccines","volume":"12","author":"Davies","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.meegid.2017.05.022_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 inducing peptides","volume":"2013","author":"Dhanda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijpara.2014.07.010","article-title":"Genome-based vaccine design: the promise for malaria and other infectious diseases","volume":"44","author":"Doolan","year":"2014","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.05.022_bb0090","first-page":"681","article-title":"SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"Comput. Appl. Biosci."},{"key":"10.1016\/j.meegid.2017.05.022_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","article-title":"MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation","volume":"76","author":"Germain","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2017.05.022_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00822942-200605010-00008","article-title":"MHCPred 2.0","volume":"5","author":"Guan","year":"2006","journal-title":"Appl. Bioinforma."},{"key":"10.1016\/j.meegid.2017.05.022_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/j.1460-2075.1985.tb03633.x","article-title":"The Leishmania receptor for macrophages is a lipid-containing glycoconjugate","volume":"4","author":"Handman","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.meegid.2017.05.022_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.05.022_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.immunol.19.1.23","article-title":"In vivo activation of antigen-specific CD4 T cells","volume":"19","author":"Jenkins","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/09723757.2005.11885937","article-title":"HLA DRB1 Gene study in different population groups from Mumbai, Maharashtra, India","volume":"5","author":"Kankonkar","year":"2005","journal-title":"Int. J. Hum. Genet."},{"key":"10.1016\/j.meegid.2017.05.022_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.meegid.2016.07.007","article-title":"Homology modelling of frequent HLA class-II alleles: a perspective to improve prediction of HLA binding peptide and understand the HLA associated disease susceptibility","volume":"44","author":"Kashyap","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.meegid.2017.05.022_bb0135","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-g) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis","volume":"116","author":"Kemp","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0145","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.meegid.2017.05.022_bb0150","doi-asserted-by":"crossref","first-page":"W89","DOI":"10.1093\/nar\/gki414","article-title":"ProFunc: a server for predicting protein function from 3D structure","volume":"33","author":"Laskowski","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2017.05.022_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3892\/etm.2013.1142","article-title":"Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis","volume":"6","author":"Li","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.meegid.2017.05.022_bb0160","first-page":"1","article-title":"Major histocompatibility complex: interaction with peptides","author":"Liu","year":"2011","journal-title":"eLS"},{"key":"10.1016\/j.meegid.2017.05.022_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"10.1016\/j.meegid.2017.05.022_bb0170","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/bioinformatics\/btm471","article-title":"Modeling the adaptive immune system: predictions and simulations","volume":"23","author":"Lundegaard","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.meegid.2017.05.022_bb0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2017.05.022_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1399-0039.2003.00062.x","article-title":"New allele frequency database: http:\/\/www.allelefrequencies.net","volume":"61","author":"Middleton","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.meegid.2017.05.022_bb0185","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.meegid.2017.05.022_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-7580-6-9","article-title":"NetMHCIIpan-2.0-improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure","volume":"6","author":"Nielsen","year":"2010","journal-title":"Immunome Res."},{"key":"10.1016\/j.meegid.2017.05.022_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nylen","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.meegid.2017.05.022_bb0200","doi-asserted-by":"crossref","first-page":"120139","DOI":"10.1098\/rsob.120139","article-title":"T-cell epitope vaccine design by immunoinformatics","volume":"3","author":"Patronov","year":"2013","journal-title":"Open Biol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0205","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.meegid.2017.05.022_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fgene.2014.00291","article-title":"Insilico analysis of hypothetical proteins unveils putative metabolic pathways and essential genes in Leishmania donovani","volume":"5","author":"Ravooru","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.meegid.2017.05.022_bb0215","series-title":"Veterinary Research Forum","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative review article","author":"Rezvan","year":"2015"},{"key":"10.1016\/j.meegid.2017.05.022_bb0220","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.meegid.2017.05.022_bb0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","article-title":"How TCRs bind MHCs, peptides, and coreceptors","volume":"24","author":"Rudolph","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0230","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modeling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0166-6851(02)00010-5","article-title":"Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis","volume":"120","author":"Santana","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0240","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","article-title":"The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes","volume":"153","author":"Sette","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2017.05.022_bb0245","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (Fucose Mannose Ligand) of Leishmania donovani: a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar","volume":"29","author":"Sousa","year":"1996","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.meegid.2017.05.022_bb0250","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2174\/138161209789105171","article-title":"HLA-DR: molecular insights and vaccine design","volume":"15","author":"Stern","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.meegid.2017.05.022_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002278","article-title":"A review of preventative methods against human leishmaniasis infection","volume":"7","author":"Stockdale","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2017.05.022_bb0260","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1084\/jem.183.5.1965","article-title":"Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes","volume":"183","author":"Topalian","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2017.05.022_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.meegid.2017.05.022_bb0270","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"Vita","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2017.05.022_bb0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"key":"10.1016\/j.meegid.2017.05.022_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"Wang","year":"2008","journal-title":"PLoS Comput. Biol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817301831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817301831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T08:18:55Z","timestamp":1719217135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134817301831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":56,"alternative-id":["S1567134817301831"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2017.05.022","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2017.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}